ÜNSAL, O. Et Al. 2022. Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2. FUTURE ONCOLOGY , vol.18, no.5 , 533-541.

ÜNSAL, O., YAZICI, O., ÖZDEMİR, N., ÇUBUKÇU, E., OCAK, B., ÜNER, A., ... ÖZET, A.(2022). Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2. FUTURE ONCOLOGY , vol.18, no.5, 533-541.

ÜNSAL, OKTAY Et Al. "Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2," FUTURE ONCOLOGY , vol.18, no.5, 533-541, 2022

ÜNSAL, OKTAY Et Al. "Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2." FUTURE ONCOLOGY , vol.18, no.5, pp.533-541, 2022

ÜNSAL, O. Et Al. (2022) . "Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2." FUTURE ONCOLOGY , vol.18, no.5, pp.533-541.

@article{article, author={OKTAY ÜNSAL Et Al. }, title={Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2}, journal={FUTURE ONCOLOGY}, year=2022, pages={533-541} }